![]() Stroke Treatment Market (Type: Ischemic Stroke and Hemorrhagic Stroke; Drug Class: Anticoagulants, Antiplatelets, Tissue plasminogen activator (tPA), Statins, Beta-Blockers, Others; Route of Administration: Oral and Parenteral; Drug Availability: Branded and Generic and Distribution Channel: Hospital Pharmacies, Online Pharmacies and Retail Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
Stroke Treatment Market – Scope of Report TMR’s report on the global stroke treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of th... もっと見る
英語原文をAIを使って翻訳しています。
SummaryStroke Treatment Market – Scope of ReportTMR’s report on the global stroke treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global stroke treatment market for the period 2019–2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global stroke treatment market from 2025 to 2035. The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the stroke treatment market. Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global stroke treatment market. The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global stroke treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global stroke treatment market. The report delves into the competitive landscape of the global stroke treatment market. Key players operating in the global stroke treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global stroke treatment market profiled in this report. Key Questions Answered in Global stroke treatment Market Report • What is the sales/revenue generated by stroke treatment across all regions during the forecast period? • What are the opportunities in the global stroke treatment market? • What are the major drivers, restraints, opportunities, and threats in the market? • Which regional market is set to expand at the fastest CAGR during the forecast period? • Which segment is expected to generate the highest revenue globally in 2035? • Which segment is projected to expand at the highest CAGR during the forecast period? • What are the market positions of different companies operating in the global market? Stroke Treatment Market – Research Objectives and Research Approach The comprehensive report on the global stroke treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products. For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period. The report analyzes the global stroke treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global stroke treatment market. Table of Contents1. Preface1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Global Stroke Treatment Market 4. Market Overview 4.1. Introduction 4.1.1. Segment Definition 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Global Stroke Treatment Market Analysis and Forecast, 2020-2035 4.4.1. Market Revenue Projections (US$ Bn) 5. Key Insights 5.1. Key Industry Events 5.2. PESTEL Analysis 5.3. Regulatory Scenario by Key Countries/Regions 5.4. PORTER’s Five Forces Analysis 5.5. Product/Brand Analysis 5.6. Supply Chain Analysis 5.7. Pipeline Analysis 6. Global Stroke Treatment Market Analysis and Forecast, by Type 6.1. Introduction & Definition 6.2. Key Findings/Developments 6.3. Market Value Forecast, by Type, 2020-2035 6.3.1. Ischemic Stroke 6.3.1.1. Thrombotic Stroke 6.3.1.2. Embolic Stroke 6.3.2. Hemorrhagic Stroke 6.3.2.1. Intracerebral Hemorrhage 6.3.2.2. Subarachnoid Hemorrhage 6.4. Market Attractiveness Analysis, by Type 7. Global Stroke Treatment Market Analysis and Forecast, by Drug Class 7.1. Introduction & Definition 7.2. Key Findings/Developments 7.3. Market Value Forecast, by Drug Class, 2020-2035 7.3.1. Anticoagulants 7.3.2. Antiplatelets 7.3.3. Tissue plasminogen activator (tPA) 7.3.4. Statins 7.3.5. Beta-Blockers 7.3.6. Others 7.4. Market Attractiveness Analysis, by Drug Class 8. Global Stroke Treatment Market Analysis and Forecast, by Route of Administration 8.1. Introduction & Definition 8.2. Key Findings/Developments 8.3. Market Value Forecast, by Route of Administration, 2020-2035 8.3.1. Oral 8.3.2. Parenteral 8.4. Market Attractiveness Analysis, by Route of Administration 9. Global Stroke Treatment Market Analysis and Forecast, by Drug Availability 9.1. Introduction & Definition 9.2. Key Findings/Developments 9.3. Market Value Forecast, by Drug Availability, 2020-2035 9.3.1. Branded 9.3.2. Generic 9.4. Market Attractiveness Analysis, by Drug Availability 10. Global Stroke Treatment Market Analysis and Forecast, by Distribution Channel 10.1. Introduction & Definition 10.2. Key Findings/Developments 10.3. Market Value Forecast, by Distribution Channel, 2020-2035 10.3.1. Hospital Pharmacies 10.3.2. Retail Pharmacies 10.3.3. Online Pharmacies 10.4. Market Attractiveness Analysis, by Distribution Channel 11. Global Stroke Treatment Market Analysis and Forecast, by Region 11.1. Key Findings 11.2. Market Value Forecast, by Region, 2020-2035 11.2.1. North America 11.2.2. Europe 11.2.3. Asia Pacific 11.2.4. Latin America 11.2.5. Middle East & Africa 11.3. Market Attractiveness Analysis, by Region 12. North America Stroke Treatment Market Analysis and Forecast 12.1. Introduction 12.1.1. Key Findings 12.2. Market Value Forecast, by Type, 2020-2035 12.2.1. Ischemic Stroke 12.2.1.1. Thrombotic Stroke 12.2.1.2. Embolic Stroke 12.2.2. Hemorrhagic Stroke 12.2.2.1. Intracerebral Hemorrhage 12.2.2.2. Subarachnoid Hemorrhage 12.3. Market Value Forecast, by Drug Class, 2020-2035 12.3.1. Anticoagulants 12.3.2. Antiplatelets 12.3.3. Tissue plasminogen activator (tPA) 12.3.4. Statins 12.3.5. Beta-Blockers 12.3.6. Others 12.4. Market Value Forecast, by Route of Administration, 2020-2035 12.4.1. Oral 12.4.2. Parenteral 12.5. Market Value Forecast, by Drug Availability, 2020-2035 12.5.1. Branded 12.5.2. Generic 12.6. Market Value Forecast, by Distribution Channel, 2020-2035 12.6.1. Hospital Pharmacies 12.6.2. Retail Pharmacies 12.6.3. Online Pharmacies 12.7. Market Value Forecast, by Country, 2020-2035 12.7.1. U.S. 12.7.2. Canada 12.8. Market Attractiveness Analysis 12.8.1. By Type 12.8.2. By Drug Class 12.8.3. By Route of Administration 12.8.4. By Drug Availability 12.8.5. By Distribution Channel 12.8.6. By Country 13. Europe Stroke Treatment Market Analysis and Forecast 13.1. Introduction 13.1.1. Key Findings 13.2. Market Value Forecast, by Type, 2020-2035 13.2.1. Ischemic Stroke 13.2.1.1. Thrombotic Stroke 13.2.1.2. Embolic Stroke 13.2.2. Hemorrhagic Stroke 13.2.2.1. Intracerebral Hemorrhage 13.2.2.2. Subarachnoid Hemorrhage 13.3. Market Value Forecast, by Drug Class, 2020-2035 13.3.1. Anticoagulants 13.3.2. Antiplatelets 13.3.3. Tissue plasminogen activator (tPA) 13.3.4. Statins 13.3.5. Beta-Blockers 13.3.6. Others 13.4. Market Value Forecast, by Route of Administration, 2020-2035 13.4.1. Oral 13.4.2. Parenteral 13.5. Market Value Forecast, by Drug Availability, 2020-2035 13.5.1. Branded 13.5.2. Generic 13.6. Market Value Forecast, by Distribution Channel, 2020-2035 13.6.1. Hospital Pharmacies 13.6.2. Retail Pharmacies 13.6.3. Online Pharmacies 13.7. Market Value Forecast, by Country/Sub-region, 2020-2035 13.7.1. Germany 13.7.2. UK 13.7.3. France 13.7.4. Italy 13.7.5. Spain 13.7.6. Rest of Europe 13.8. Market Attractiveness Analysis 13.8.1. By Type 13.8.2. By Drug Class 13.8.3. By Route of Administration 13.8.4. By Drug Availability 13.8.5. By Distribution Channel 13.8.6. By Country/Sub-region List of Tables/GraphsList of FiguresFigure 01: Global Stroke Treatment Market Value (US$ Bn) Forecast, 2020-2035 Figure 02: Global Stroke Treatment Market Value Share Analysis, By Type, 2024 and 2035 Figure 03: Global Stroke Treatment Market Attractiveness Analysis, By Type, 2025-2035 Figure 04: Global Stroke Treatment Market Revenue (US$ Bn), by Ischemic Stroke, 2020-2035 Figure 05: Global Stroke Treatment Market Value Share Analysis, By Drug Class, 2024 and 2035 Figure 06: Global Stroke Treatment Market Attractiveness Analysis, By Drug Class, 2025-2035 Figure 07: Global Stroke Treatment Market Revenue (US$ Bn), by Anticoagulants, 2020-2035 Figure 08: Global Stroke Treatment Market Revenue (US$ Bn), by Antiplatelets, 2020-2035 Figure 09: Global Stroke Treatment Market Revenue (US$ Bn), by Tissue plasminogen activator (tPA), 2020-2035 Figure 10: Global Stroke Treatment Market Revenue (US$ Bn), by Statins, 2020-2035 Figure 11: Global Stroke Treatment Market Revenue (US$ Bn), by Beta-Blockers, 2020-2035 Figure 12: Global Stroke Treatment Market Revenue (US$ Bn), by Others, 2020-2035 Figure 13: Global Stroke Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035 Figure 14: Global Stroke Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035 Figure 15: Global Stroke Treatment Market Revenue (US$ Bn), by Oral, 2020-2035 Figure 16: Global Stroke Treatment Market Revenue (US$ Bn), by Parenteral, 2020-2035 Figure 17: Global Stroke Treatment Market Value Share Analysis, By Drug Availability, 2024 and 2035 Figure 18: Global Stroke Treatment Market Attractiveness Analysis, By Drug Availability, 2025-2035 Figure 19: Global Stroke Treatment Market Revenue (US$ Bn), by Branded, 2020-2035 Figure 20: Global Stroke Treatment Market Revenue (US$ Bn), by Generic, 2020-2035 Figure 21: Global Stroke Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035 Figure 22: Global Stroke Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035 Figure 23: Global Stroke Treatment Market Revenue (US$ Bn), by Hospital Pharmacies, 2020-2035 Figure 24: Global Stroke Treatment Market Revenue (US$ Bn), by Retail Pharmacies, 2020-2035 Figure 25: Global Stroke Treatment Market Revenue (US$ Bn), by Online Pharmacies, 2020-2035 Figure 26: Global Stroke Treatment Market Value Share Analysis, By Region, 2024 and 2035 Figure 27: Global Stroke Treatment Market Attractiveness Analysis, By Region, 2025-2035 Figure 28: North America - Stroke Treatment Market Value (US$ Bn) Forecast, 2020-2035 Figure 29: North America - Stroke Treatment Market Value Share Analysis, by Country, 2024 and 2035 Figure 30: North America - Stroke Treatment Market Attractiveness Analysis, by Country, 2025-2035 Figure 31: North America - Stroke Treatment Market Value Share Analysis, By Type, 2024 and 2035 Figure 32: North America - Stroke Treatment Market Attractiveness Analysis, By Type, 2025-2035 Figure 33: North America - Stroke Treatment Market Value Share Analysis, By Drug Class, 2024 and 2035 Figure 34: North America - Stroke Treatment Market Attractiveness Analysis, By Drug Class, 2025-2035 Figure 35: North America - Stroke Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035 Figure 36: North America - Stroke Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035 Figure 37: North America - Stroke Treatment Market Value Share Analysis, By Drug Availability, 2024 and 2035 Figure 38: North America - Stroke Treatment Market Attractiveness Analysis, By Drug Availability, 2025-2035 Figure 39: North America - Stroke Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035 Figure 40: North America - Stroke Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035 Figure 41: Europe - Stroke Treatment Market Value (US$ Bn) Forecast, 2020-2035 Figure 42: Europe - Stroke Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035 Figure 43: Europe - Stroke Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035 Figure 44: Europe - Stroke Treatment Market Value Share Analysis, By Type, 2024 and 2035 Figure 45: Europe - Stroke Treatment Market Attractiveness Analysis, By Type, 2025-2035 Figure 46: Europe - Stroke Treatment Market Value Share Analysis, By Drug Class, 2024 and 2035 Figure 47: Europe - Stroke Treatment Market Attractiveness Analysis, By Drug Class, 2025-2035 Figure 48: Europe - Stroke Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035 Figure 49: Europe - Stroke Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035 Figure 50: Europe - Stroke Treatment Market Value Share Analysis, By Drug Availability, 2024 and 2035 Figure 51: Europe - Stroke Treatment Market Attractiveness Analysis, By Drug Availability, 2025-2035 Figure 52: Europe - Stroke Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035 Figure 53: Europe - Stroke Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035 Figure 54: Asia Pacific - Stroke Treatment Market Value (US$ Bn) Forecast, 2020-2035 Figure 55: Asia Pacific - Stroke Treatment Market Value Share Analysis, by Country/Sub-region, 2024 and 2035 Figure 56: Asia Pacific - Stroke Treatment Market Attractiveness Analysis, by Country/Sub-region, 2025-2035 Figure 57: Asia Pacific - Stroke Treatment Market Value Share Analysis, By Type, 2024 and 2035 Figure 58: Asia Pacific - Stroke Treatment Market Attractiveness Analysis, By Type, 2025-2035 Figure 59: Asia Pacific - Stroke Treatment Market Value Share Analysis, By Drug Class, 2024 and 2035 Figure 60: Asia Pacific - Stroke Treatment Market Attractiveness Analysis, By Drug Class, 2025-2035 Figure 61: Asia Pacific - Stroke Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035 Figure 62: Asia Pacific - Stroke Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035 Figure 63: Asia Pacific - Stroke Treatment Market Value Share Analysis, By Drug Availability, 2024 and 2035 Figure 64: Asia Pacific - Stroke Treatment Market Attractiveness Analysis, By Drug Availability, 2025-2035 Figure 65: Asia Pacific - Stroke Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035 Figure 66: Asia Pacific - Stroke Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035 Figure 67: Latin America - Stroke Treatment Market Value (US$ Bn) Forecast, 2020-2035 Figure 68: Latin America - Stroke Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035 Figure 69: Latin America - Stroke Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035 Figure 70: Latin America - Stroke Treatment Market Value Share Analysis, By Type, 2024 and 2035 Figure 71: Latin America - Stroke Treatment Market Attractiveness Analysis, By Type, 2025-2035 Figure 72: Latin America - Stroke Treatment Market Value Share Analysis, By Drug Class, 2024 and 2035 Figure 73: Latin America - Stroke Treatment Market Attractiveness Analysis, By Drug Class, 2025-2035 Figure 74: Latin America - Stroke Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035 Figure 75: Latin America - Stroke Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035 Figure 76: Latin America - Stroke Treatment Market Value Share Analysis, By Drug Availability, 2024 and 2035 Figure 77: Latin America - Stroke Treatment Market Attractiveness Analysis, By Drug Availability, 2025-2035 Figure 78: Latin America - Stroke Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035 Figure 79: Latin America - Stroke Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035 Figure 80: Middle East & Africa - Stroke Treatment Market Value (US$ Bn) Forecast, 2020-2035 Figure 81: Middle East & Africa - Stroke Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035 Figure 82: Middle East & Africa - Stroke Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035 Figure 83: Middle East & Africa - Stroke Treatment Market Value Share Analysis, By Type, 2024 and 2035 Figure 84: Middle East & Africa - Stroke Treatment Market Attractiveness Analysis, By Type, 2025-2035 Figure 85: Middle East & Africa - Stroke Treatment Market Value Share Analysis, By Drug Class, 2024 and 2035 Figure 86: Middle East & Africa - Stroke Treatment Market Attractiveness Analysis, By Drug Class, 2025-2035 Figure 87: Middle East & Africa - Stroke Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035 Figure 88: Middle East & Africa - Stroke Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035 Figure 89: Middle East & Africa - Stroke Treatment Market Value Share Analysis, By Drug Availability, 2024 and 2035 Figure 90: Middle East & Africa - Stroke Treatment Market Attractiveness Analysis, By Drug Availability, 2025-2035 Figure 91: Middle East & Africa - Stroke Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035 Figure 92: Middle East & Africa - Stroke Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医薬)の最新刊レポート
Transparency Market Research社の製薬分野での最新刊レポート
本レポートと同じKEY WORD(drug)の最新刊レポート
よくあるご質問Transparency Market Research社はどのような調査会社ですか?トレンスペアレンシーマーケットリサーチ(Transparency Market Research /TMR)は市場参入やホワイトスペースの特定、新商品や新サービスの立ち上げ、戦略的M&Aなどの実現のた... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2025/06/17 10:26 146.08 円 169.07 円 200.84 円 |